More than 9 months into the combat against COVID-19, the world has seen battles being stepped up on all fronts in the search for an effective therapy. While new drugs are being developed, old drugs are repurposed as potential treatment for COVID-19, and a plethora others are upcoming in the pipeline.
The population-based risk prediction algorithm QCOVID demonstrates very high levels of discrimination for deaths and hospital admissions due to the novel coronavirus disease (COVID-19), according to the results of a national derivation and validation cohort study.
A community initiative targeted at metastatic breast cancer (mBC) patients has recently been launched by the Breast Cancer Welfare Association Malaysia (BCWA). Called #UnPause, the initiative aims to rally mBC patients to live their lives to the fullest. It further aims to raise awareness of mBC among the public and prevent treatment disruption as a result of the COVID-19 pandemic. #UnPause is also supported by Pfizer.
Having vaccination against influenza during pregnancy was not associated with an increased risk of autism spectrum disorder (ASD) in the offspring, a large cohort study reveals — providing more support for vaccination during pregnancy.
Patients who recover from, and then subsequently test positive for, the novel coronavirus disease (COVID-19) show no clinical, laboratory, and treatment distinctions from patients with a more typical disease course, according to a recent study.
Peri- and postmenopausal women who have an active sex life and exercise regularly have proven to be quite resilient in confinement in the wake of the coronavirus outbreak, a study has found. On the other hand, those who use antidepressants are more likely to succumb to adversity and hence have poorer quality of life.
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.